Paper3594575
Protection from tumor necrosis factor cytotoxicity by protease inhibitors.
Ruggiero V and 2 others. Cell Immunol, 1987. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Papers, record 3594575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3594575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycoproteins | Major topic |
| Protease Inhibitors | Major topic |
| Animals | |
| Cell Survival | |
| Cells, Cultured | |
| Humans | |
| Mice | |
| Molecular Weight | |
| Protein Biosynthesis | |
| Recombinant Proteins | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA29895 | NCI NIH HHS | United States | R01CA029895 | PubMed and NIH |
Source NIH RePORTER
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21787418 | Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. | Arthritis Res Ther | 2011 | https://conductscience.org/library/papers/21787418 | PubMed |
| 21705336 | Impaired spermatogenesis and fertility in mice carrying a mutation in the Spink2 gene expressed predominantly in testes. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21705336 | PubMed |
| 20169397 | Non-caspase proteases: triggers or amplifiers of apoptosis? | Cell Mol Life Sci | 2010 | https://conductscience.org/library/papers/20169397 | PubMed |
| 11381085 | Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. | J Cell Biol | 2001 | https://conductscience.org/library/papers/11381085 | PubMed |
| 10884417 | Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10884417 | PubMed |
| 9120020 | Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9120020 | PubMed |
| 8344250 | Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. | EMBO J | 1993 | https://conductscience.org/library/papers/8344250 | PubMed |
| 8256858 | Protection from tumor necrosis factor-mediated cytolysis by platelets. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8256858 | PubMed |
| 8228816 | Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. | J Exp Med | 1993 | https://conductscience.org/library/papers/8228816 | PubMed |
| 8163936 | T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. | J Exp Med | 1994 | https://conductscience.org/library/papers/8163936 | PubMed |
| 7964487 | Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. | J Exp Med | 1994 | https://conductscience.org/library/papers/7964487 | PubMed |
| 3119758 | Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. | J Exp Med | 1987 | https://conductscience.org/library/papers/3119758 | PubMed |
| 2322985 | Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2322985 | PubMed |
| 1916153 | Significance of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in the pathogenesis of fulminant hepatitis: possible involvement of serine protease in TNF-mediated liver injury. | Gastroenterol Jpn | 1991 | https://conductscience.org/library/papers/1916153 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3594575
GET https://conductscience.org/api/papers/v1/3594575/authors